Selected research
Market Structure
Global Pet Whole Blood and Blood Components Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pet Whole Blood and Blood Components market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pet Whole Blood and Blood Components include Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe and Lake Immunogenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pet Whole Blood and Blood Components market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pet Whole Blood and Blood Components and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pet Whole Blood and Blood Components sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Whole Blood and Blood Components market size, projected growth trends, production technologies, key applications, and end-use industries.
Pet Whole Blood and Blood Components Segment by Company
Thermo Fisher Scientific
Moregate BioTech
Bovogen Biologicals (ANZCO Foods Healthcare)
Pel-Freez, LLC
HemoStat Laboratories
CellSera Australia (Auckland BioSciences)
Animal Technologies
Serana Europe
Lake Immunogenics
MoreCare. Inc.
Nanjing BioChannel Biotechnology Co., Ltd
Pet Whole Blood and Blood Components Segment by Type
Canine
Feline
Bovine
Sheep
Others
Pet Whole Blood and Blood Components Segment by Application
Veterinary Hospital
Clinic
Other
Pet Whole Blood and Blood Components Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Whole Blood and Blood Components market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Whole Blood and Blood Components and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Whole Blood and Blood Components.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pet Whole Blood and Blood Components market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Whole Blood and Blood Components manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Whole Blood and Blood Components in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pet Whole Blood and Blood Components in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Canine
- Feline
- Bovine
- Sheep
- Others
Applications
- Veterinary Hospital
- Clinic
- Other
Companies covered
- Thermo Fisher Scientific
- Moregate BioTech
- Bovogen Biologicals (ANZCO Foods Healthcare)
- Pel-Freez, LLC
- HemoStat Laboratories
- CellSera Australia (Auckland BioSciences)
- Animal Technologies
- Serana Europe
- Lake Immunogenics
- MoreCare. Inc.
- Nanjing BioChannel Biotechnology Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pet Whole Blood and Blood Components Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pet Whole Blood and Blood Components Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pet Whole Blood and Blood Components Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pet Whole Blood and Blood Components Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pet Whole Blood and Blood Components Market Dynamics
- 2.1 Pet Whole Blood and Blood Components Industry Trends
- 2.2 Pet Whole Blood and Blood Components Industry Drivers
- 2.3 Pet Whole Blood and Blood Components Industry Opportunities and Challenges
- 2.4 Pet Whole Blood and Blood Components Industry Restraints
3 Pet Whole Blood and Blood Components Market by Manufacturers
- 3.1 Global Pet Whole Blood and Blood Components Revenue by Manufacturers (2021-2026)
- 3.2 Global Pet Whole Blood and Blood Components Sales by Manufacturers (2021-2026)
- 3.3 Global Pet Whole Blood and Blood Components Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pet Whole Blood and Blood Components Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pet Whole Blood and Blood Components Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pet Whole Blood and Blood Components Manufacturers, Product Type & Application
- 3.7 Global Pet Whole Blood and Blood Components Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pet Whole Blood and Blood Components Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pet Whole Blood and Blood Components Players Market Share by Revenue in 2025
- 3.8.3 2025 Pet Whole Blood and Blood Components Tier 1, Tier 2, and Tier 3
4 Pet Whole Blood and Blood Components Market by Type
- 4.1 Pet Whole Blood and Blood Components Type Introduction
- 4.1.1 Canine
- 4.1.2 Feline
- 4.1.3 Bovine
- 4.1.4 Sheep
- 4.1.5 Others
- 4.2 Global Pet Whole Blood and Blood Components Sales by Type
- 4.2.1 Global Pet Whole Blood and Blood Components Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pet Whole Blood and Blood Components Sales by Type (2021-2032)
- 4.2.3 Global Pet Whole Blood and Blood Components Sales Market Share by Type (2021-2032)
- 4.3 Global Pet Whole Blood and Blood Components Revenue by Type
- 4.3.1 Global Pet Whole Blood and Blood Components Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
- 4.3.3 Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2021-2032)
5 Pet Whole Blood and Blood Components Market by Application
- 5.1 Pet Whole Blood and Blood Components Application Introduction
- 5.1.1 Veterinary Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Pet Whole Blood and Blood Components Sales by Application
- 5.2.1 Global Pet Whole Blood and Blood Components Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pet Whole Blood and Blood Components Sales by Application (2021-2032)
- 5.2.3 Global Pet Whole Blood and Blood Components Sales Market Share by Application (2021-2032)
- 5.3 Global Pet Whole Blood and Blood Components Revenue by Application
- 5.3.1 Global Pet Whole Blood and Blood Components Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
- 5.3.3 Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2021-2032)
6 Global Pet Whole Blood and Blood Components Sales by Region
- 6.1 Global Pet Whole Blood and Blood Components Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pet Whole Blood and Blood Components Sales by Region (2021-2032)
- 6.2.1 Global Pet Whole Blood and Blood Components Sales by Region (2021-2026)
- 6.2.2 Global Pet Whole Blood and Blood Components Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pet Whole Blood and Blood Components Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pet Whole Blood and Blood Components Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pet Whole Blood and Blood Components Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pet Whole Blood and Blood Components Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pet Whole Blood and Blood Components Revenue by Region
- 7.1 Global Pet Whole Blood and Blood Components Revenue by Region
- 7.1.1 Global Pet Whole Blood and Blood Components Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pet Whole Blood and Blood Components Revenue by Region (2021-2026)
- 7.1.3 Global Pet Whole Blood and Blood Components Revenue by Region (2027-2032)
- 7.1.4 Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pet Whole Blood and Blood Components Revenue (2021-2032)
- 7.2.2 North America Pet Whole Blood and Blood Components Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pet Whole Blood and Blood Components Revenue (2021-2032)
- 7.3.2 Europe Pet Whole Blood and Blood Components Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pet Whole Blood and Blood Components Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pet Whole Blood and Blood Components Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pet Whole Blood and Blood Components Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pet Whole Blood and Blood Components Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific
- 8.1.1 Thermo Fisher Scientific Company Information
- 8.1.2 Thermo Fisher Scientific Business Overview
- 8.1.3 Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio
- 8.1.5 Thermo Fisher Scientific Recent Developments
- 8.2 Moregate BioTech
- 8.2.1 Moregate BioTech Company Information
- 8.2.2 Moregate BioTech Business Overview
- 8.2.3 Moregate BioTech Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio
- 8.2.5 Moregate BioTech Recent Developments
- 8.3 Bovogen Biologicals (ANZCO Foods Healthcare)
- 8.3.1 Bovogen Biologicals (ANZCO Foods Healthcare) Company Information
- 8.3.2 Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview
- 8.3.3 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio
- 8.3.5 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments
- 8.4 Pel-Freez, LLC
- 8.4.1 Pel-Freez, LLC Company Information
- 8.4.2 Pel-Freez, LLC Business Overview
- 8.4.3 Pel-Freez, LLC Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio
- 8.4.5 Pel-Freez, LLC Recent Developments
- 8.5 HemoStat Laboratories
- 8.5.1 HemoStat Laboratories Company Information
- 8.5.2 HemoStat Laboratories Business Overview
- 8.5.3 HemoStat Laboratories Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio
- 8.5.5 HemoStat Laboratories Recent Developments
- 8.6 CellSera Australia (Auckland BioSciences)
- 8.6.1 CellSera Australia (Auckland BioSciences) Company Information
- 8.6.2 CellSera Australia (Auckland BioSciences) Business Overview
- 8.6.3 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio
- 8.6.5 CellSera Australia (Auckland BioSciences) Recent Developments
- 8.7 Animal Technologies
- 8.7.1 Animal Technologies Company Information
- 8.7.2 Animal Technologies Business Overview
- 8.7.3 Animal Technologies Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Animal Technologies Pet Whole Blood and Blood Components Product Portfolio
- 8.7.5 Animal Technologies Recent Developments
- 8.8 Serana Europe
- 8.8.1 Serana Europe Company Information
- 8.8.2 Serana Europe Business Overview
- 8.8.3 Serana Europe Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Serana Europe Pet Whole Blood and Blood Components Product Portfolio
- 8.8.5 Serana Europe Recent Developments
- 8.9 Lake Immunogenics
- 8.9.1 Lake Immunogenics Company Information
- 8.9.2 Lake Immunogenics Business Overview
- 8.9.3 Lake Immunogenics Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio
- 8.9.5 Lake Immunogenics Recent Developments
- 8.10 MoreCare. Inc.
- 8.10.1 MoreCare. Inc. Company Information
- 8.10.2 MoreCare. Inc. Business Overview
- 8.10.3 MoreCare. Inc. Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio
- 8.10.5 MoreCare. Inc. Recent Developments
- 8.11 Nanjing BioChannel Biotechnology Co., Ltd
- 8.11.1 Nanjing BioChannel Biotechnology Co., Ltd Company Information
- 8.11.2 Nanjing BioChannel Biotechnology Co., Ltd Business Overview
- 8.11.3 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio
- 8.11.5 Nanjing BioChannel Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pet Whole Blood and Blood Components Value Chain Analysis
- 9.1.1 Pet Whole Blood and Blood Components Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pet Whole Blood and Blood Components Production Mode & Process
- 9.2 Pet Whole Blood and Blood Components Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pet Whole Blood and Blood Components Distributors
- 9.2.3 Pet Whole Blood and Blood Components Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst